Stock UniverseDerived research view · source repositories remain read-only

Ironwood Pharmaceuticals, Inc. (IRWD)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Speculative
Selection Score
24.70
Global Rank
2837
Market Cap
557.66M
Latest Close
3.31
RS Composite
-18.68% · G#2574

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-31.47%
3M
-5.43%
6M
-11.26%
1Y
451.67%
3Y
-69.58%
5Y
-71.39%
10Y
-68.36%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.33M · 30-day average: 2.47M · Max drawdown over stored range: -96.77%

Research Snapshot

Relative Strength vs SPX

RS Composite-18.68%
20D RS-21.26%
60D RS-19.03%
120D RS-17.05%
Global RS Rank2574 · 23.28% percentile
Watch+Speculative RS Rank1594 · 23.99% percentile
Group ScopeWatch+Speculative
Primary RS Rank282 · 38.43% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank348 / 701
Primary Percentile50.50
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for IRWD.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue389.523413.753410.596442.735351.41296.151
Revenue Growth (YoY)-9.078%6.22%-0.763%7.827%-20.627%-15.725%
Gross Profit298.325343.348405.66436.587343.858201.015
Operating Income158.322232.215250.337195.83695.717118.759
Free Cash Flow166.994261.63273.627183.154103.407127.01
Free Cash Flow Per Share1.0391.5911.4691.1780.6460.779
EPS (Diluted) GAAP0.663.210.963512-6.450.0055310.148397
EPS Growth378.844%386.364%-69.984%6400%6400%2583.005%
EPS Non-GAAP
Gross Margin76.587%82.984%98.798%98.611%97.851%67.876%
Operating Margin40.645%56.124%60.969%44.233%27.238%40.101%
Profit Margin27.258%127.721%42.637%-226.374%0.25%8.11%
Free Cash Flow Margin42.871%63.233%66.641%41.369%29.426%42.887%
Shares Outstanding (Diluted)160.655164.418186.312155.435160.084162.983
Shares Change (YoY)2.969%2.342%13.316%-16.573%2.991%1.811%

SEC Quarterly Fundamentals

No processed quarterly rows for IRWD.